Zobrazeno 1 - 10
of 34
pro vyhledávání: '"Qunhao Zheng"'
Autor:
Jianjian Qiu, Hancui Lin, Dongmei Ke, Yilin Yu, Jiaying Xu, Hejin Qiu, Qunhao Zheng, Hui Li, Hongying Zheng, Lingyun Liu, Zhiping Wang, Qiwei Yao, Jiancheng Li
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
BackgroundTo explore the effective dose to immune cells (EDIC) for better prognosis while avoiding radiation-induced lymphopenia (RIL) in patients with locally advanced esophageal squamous cell carcinoma (ESCC).Materials and methodsOverall, 381 patie
Externí odkaz:
https://doaj.org/article/3275143ed16541ff938b1a1ae342bc7d
Autor:
Zhiyu Huang, Qunhao Zheng, Yilin Yu, Hongying Zheng, Yahua Wu, Zhiping Wang, Lingyun Liu, Mengyan Zhang, Tianxiu Liu, Hui Li, Jiancheng Li
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-11 (2022)
Abstract Accumulating evidence indicates that inflammation and nutrition status are associated with clinical outcomes in patients with various malignancies. This study aimed to evaluate the prognostic significance of the pretreatment platelet to albu
Externí odkaz:
https://doaj.org/article/66760982aa7f4a30bf3a978495fb652f
Autor:
Jun Yang, Mingqiang Lin, Mengyan Zhang, Zhiping Wang, Hancui Lin, Yilin Yu, Qunhao Zheng, Xiaohui Chen, Yahua Wu, Qiwei Yao, Jiancheng Li
Publikováno v:
Genetics Research, Vol 2023 (2023)
Background. Advanced glycation end products’ receptor (AGER) is a multiligand receptor that interacts with a wide range of ligands. Previous studies have shown that abnormal AGER expression is closely related to immune infiltration and tumorigenesi
Externí odkaz:
https://doaj.org/article/28008b581d834e7fad4cabf900efed5f
Autor:
Jun Yang, Jifang Zheng, Jianjian Qiu, Mengyan Zhang, Lingyun Liu, Zhiping Wang, Qunhao Zheng, Yanyan Liu, Mingqiu Chen, Jiancheng Li
Publikováno v:
Journal of Immunology Research, Vol 2023 (2023)
Background. Systemic inflammation may be involved in the entire cancer process as a promoter and is associated with antitumor immunity. The systemic immune-inflammation index (SII) has been shown to be a promising prognostic factor. However, the rela
Externí odkaz:
https://doaj.org/article/e2aec61574884e30ad48ba56f25f5ac0
Autor:
Qiwei Yao, Yilin Yu, Zhiping Wang, Mengyan Zhang, Jiayu Ma, Yahua Wu, Qunhao Zheng, Jiancheng Li
Publikováno v:
BMC Cancer, Vol 22, Iss 1, Pp 1-17 (2022)
Abstract Background Calcium-activated nucleotidase 1 (CANT1), functions as a calcium-dependent nucleotidase with a preference for UDP. However, the potential clinical value of CANT1 in lung adenocarcinoma (LA) has not been fully clarified. Thus, we s
Externí odkaz:
https://doaj.org/article/1449a0c6f669491fad40c3f2c7c5d91a
Autor:
Qunhao Zheng, Zhiping Wang, Mengyan Zhang, Yilin Yu, Rui Chen, Tianzhu Lu, Lingyun Liu, Jiayu Ma, Tianxiu Liu, Hongying Zheng, Hui Li, Jiancheng Li
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-18 (2021)
Abstract Background Studies have shown that the Sec61 gamma subunit (SEC61G) is overexpressed in several tumors and could serve as a potential prognostic marker. However, the correlation between SEC61G and lung adenocarcinoma (LUAD) remains unclear.
Externí odkaz:
https://doaj.org/article/fe7a6cf687e24966832fd6bf854892c5
Autor:
Haishan Wu, Yilin Yu, Qunhao Zheng, Tianxiu Liu, Yahua Wu, Zhiping Wang, Hongying Zheng, Lingyun Liu, Jiancheng Li
Publikováno v:
Radiation Oncology, Vol 16, Iss 1, Pp 1-14 (2021)
Abstract Objective There is still no definitely therapeutic evidence of a beneficial effect of chemotherapy with radiotherapy for older patients with esophageal squamous cell carcinoma (ESCC). We aim to determine the influence of chemoradiotherapy (C
Externí odkaz:
https://doaj.org/article/b601ce518ed347428f9d7922dd7df0bd
Autor:
Jianjian Qiu, Dongmei Ke, Hancui Lin, Yilin Yu, Qunhao Zheng, Hui Li, Hongying Zheng, Lingyun Liu, Jiancheng Li
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
ObjectiveRadiation esophagitis (RE) is a common adverse effect in small cell lung cancer (SCLC) patients undergoing thoracic radiotherapy. We aim to develop a novel nomogram to predict the acute severe RE (grade≥2) receiving chemoradiation in SCLC
Externí odkaz:
https://doaj.org/article/7080935226b04fd6981bca7e0ca6ae5c
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-15 (2021)
Abstract GREB1L is a protein-coding gene that is an important paralog of GREB1. However, its effects in lung adenocarcinoma (LUAD) have not been determined. Thus, we evaluated the prognostic value of GREB1L in LUAD using bioinformatics approaches. In
Externí odkaz:
https://doaj.org/article/7612221b6cdc45ff92169819ce01f275
Autor:
Yilin Yu, Haishan Wu, Jianjian Qiu, Dongmei Ke, Yahua Wu, Mingqiang Lin, Tianxiu Liu, Qunhao Zheng, Hongying Zheng, Jun Yang, Zhiping Wang, Hui Li, Lingyun Liu, Qiwei Yao, Jiancheng Li, Wenfang Cheng, Xiaohui Chen
Publikováno v:
Frontiers in Nutrition, Vol 9 (2022)
ObjectiveNo study has reported the risk stratification of BMI and PNI in patients with locally advanced esophageal squamous cell carcinoma (ESCC) undergoing definitive chemoradiotherapy (dCRT). This study aimed to construct a risk stratification to g
Externí odkaz:
https://doaj.org/article/bf0107713cfe43d784cfeb1474ac4ed0